- How to Gauge Your Personal Risk For a Hernia
- Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado
- How NYU Langone built 1 of the nation’s fastest-growing GI divisions
- BCBS study: Hospital AI billing tools may be driving up healthcare costs by billions
- The transition gap: How RCA is using recovery housing to prevent relapse
- CMS moves forward with 3rd round of Medicare drug negotiations
- Kroger pharmacies add Zepbound KwikPen
- Nurses navigate AI-generated health information at bedside
- Louisiana senator resumes push to repeal water fluoridation program
- HCA’s highest-earning executives in 2025
- HCA’s highest-earning executives in 2025
- CHS Alabama hospital CEO heads to Florida
- RWJBarnabas New Jersey hospital taps new COO
- Why some health system CEOs are opting out of cross-market expansion
- Stanford Health Care leader to advise agentic AI startup
- Piedmont, Encompass tap CEO for planned Georgia hospital
- Inside Virginia’s 1st ‘tri-accredited’ bariatric surgery center
- The red flags DSOs can’t afford to ignore
- About 82% of public Medicare Advantage rate notice comments tied to ‘dark money’ group: KFF
- 10 federal government, policy updates for dentists to know
- The highest-paid ophthalmologist in the 10 largest Northeastern cities
- Arizona cardiology group pays $4.75M to settle false claims allegations
- Why AI is keeping dental practice owners up at night
- OSF HealthCare uses text outreach after ED visits — and sees 33% engagement
- Medicare spending on ASCs jumps 16% in 1 year: MedPAC
- The uneven competition in physician markets
- ‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
- Judge grants Mississippi hospital pause on Medicaid debt repayment
- Inside the erosion of independence in cardiology
- OIG green-lights ASC cataract supply discount proposal
- Children’s Hospital of Philadelphia anesthesiologist receives lifetime achievement award
- Oceans Behavioral Hospital debuts virtual outpatient program
- UF Health opens 24K-square-foot orthopedic surgical center
- Illinois health association to open $4M dental practice
- 30+ dental industry updates in California, Florida and Texas
- Heartland Dental expands in 4 states
- Crestwood Behavioral Health names program chief
- Dartmouth hospital launches social work department
- Georgia health system launches new digital patient billing system
- 5 DSOs making headlines
- Oceans behavioral health hospital taps CEO
- Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members
- Pediatric dental, orthodontic practice building sold for $4.4M
- San Francisco secures $100M to expand behavioral health treatment to 3 sites
- How nursing backgrounds shaped 2 revenue cycle leaders
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Bad News for Multitaskers: Your Brain Can’t Really Do It
- OSF HealthCare uses digital therapeutics to create a digital path to care
- Former Tenet CFO joins Acadia Healthcare board
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- Microsoft Unveils AI Health Tool That Can Read Your Medical Records
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- The feds will overpay Medicare Advantage plans by $76B this year, MedPAC estimates
- FDA Launches New Adverse Event Look-Up Tool
- FDA Launches New Adverse Event Look-Up Tool
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- Bayer found to have discredited pharma industry after Roche row
- Industry Voices—Fast answers, fragile data: the trust problem in AI-driven healthcare analytics
- Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
- GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy
- Experts Weigh in on Digital Health Wearables for Neurological Health
- Ultra-Processed Foods Bad For Bone Health, Researchers Say
- AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Fertility Treatments Aren't Linked To Added Cancer Risk For Women, Study Concludes
- There's One Simple Way Cancer Patients Can Ward Off 'Chemo Brain,' Study Finds
- Younger Stroke Survivors Face Unique Mental Health Hurdles
- 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success
- Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
- Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
- Doctors Warn of a Deadly Complication From Measles Outbreaks
- FDA scolds CDMO Simtra with warning letter over contamination fumbles
- FDA fires off another manufacturing-related CRL, this one to Hyloris
- Hospital margins take a dive
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- Medicare Advantage spending 14% higher than fee for service: Report
- Washington hospital to close pediatric rehab clinic
- New Jersey system partners with health center ahead of ED closure
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Dana-Farber boosts operating margin to 8.4% in Q1
- Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- At HIMSS26, Dr. Oz, CMS officials push agentic AI adoption. Are Medicare beneficiaries ready?
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Genetic Test May Predict Leukemia Relapse Risk
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- Microsoft unveils Copilot Health as an AI health companion for consumers
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Patent expirations push biopharma industry toward a tougher 2026
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- NYU Stern report calls for private equity reforms to safeguard quality of care
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
- Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington
"Should Texas be allowed to administer “gender-affirming care” to minors? That’s the question at the heart of Senate Bill 14 / House Bill 1686, which seeks to ban it. Proponents of the controversial practice argue that “legislatures shouldn’t be practicing medicine.” But recent testimony from pro-affirming medical professionals before the Texas legislature suggests the need for just such oversight. Delivering false or misleading testimony about minor surgery, mental health, and the evidence backing gender medicine, opponents of the ban inadvertently proved that it is justified.
Start with the question of whether “gender-affirming” surgeries are performed on minors. Last week, physician Cody Miller Pyke assured Texas state senators that “children under the age of eighteen in this country do not have gender reassignment surgery. There isn’t a single case. . . . The rhetoric of mutilating children with scalpels is just fictitious.” Louis Apel, president of the local chapter of the American Academy of Pediatrics, and Jessica Zwiener, a Houston-based endocrinologist, testified that “surgeries are not part of the standard of care for minors.” Zwiener also insisted that “[n]o one is touching these kids’ genitals. There’s not surgery done on minors.”
These physicians are wrong...."
https://www.city-journal.org/article/making-the-case-for-the-other-side
According to Heritage Action, the number of states proposing such bills is now at 40/+.
Heartlander put out this detailed and well-sourced report back in March. Hot links do not copy well, but are available in the original article.
This coming week the Missouri Senate will again see floor debate on Senate Bill 49, legislation designed to protect children from dangerous cross-sex hormones and experimental surgeries.
Especially following the alarming whistleblower reports coming out of the Washington University Transgender Center at St. Louis Children’s Hospital, this common-sense legislation should be an easy win for Missouri families and lawmakers. Senate Democrats, however, continue to block the bill’s path forward.
While left-wing radicals continue to mischaracterize this legislation, it is first important to understand what this law would do, if enacted.
Titled the “Missouri Save Adolescents from Experimentation (SAFE) Act,” this bill would prohibit physicians or other health care providers from providing “sex transition” procedures to minors. The legislation also provides safeguards for medically verifiable disorders of sex development that require medical attention, an important distinction in this highly-charged political debate.
Children, barely of school age, are being subjected to a questionable diagnosis of gender dysphoria that promotes surgeries and prescriptions for cross-sex hormones that are dangerous, life-altering and permanent. This fad-driven form of medical treatment on children is cruel and oftentimes leads to a lifetime of misery, pain and untreated mental illness.
It is wrong to assume everyone advocating for these surgeries and treatments is “doing it for the children.” In fact, providing pharmaceuticals and surgery for children suffering from gender confusion or dysphoria has become a very profitable industry. The surgeries and cross-sex hormone drugs run into the hundreds of thousands of dollars.
This is designer science, scientifically and clinically unproven, and it is being used to target confused parents and vulnerable children for political purposes and for profit. What is certain, however, is that these children will suffer from lifelong medical dependencies that enrich pharmaceutical and medical service providers with little to show in terms of patient benefit.
In reality, after a so-called “sex reassignment” surgery, girls and boys are nearly 20 times more likely to die from suicide than the general population. Up to 98% of children who struggle with their sex as a boy or a girl come to accept their biological sex by adulthood.
The long-term effects of puberty blockers and cross-sex hormones have not been extensively studied. But it’s already clear they can lead to infertility and other irreversible harmful effects that must be dealt with as children mature.
The Missouri Senate is right to focus on protecting children’s health and safety, especially given the recent revelations of negligence, malfeasance, and coercion that have occurred at the Washington University Transgender Center at St. Louis Children’s Hospital. These so-called “transition services” that amputate or severely alter healthy body parts cause irreversible damage that impacts children for the rest of their lives.
Society does not allow minors to get tattoos, purchase cigarettes or vote in elections – we recognize that minors are not ready to make life-altering decisions. Why should children or coerced parents be permitted to allow these cross-sex hormones and surgeries unquestioningly?
Our children deserve quality care and protection from junk science. Body dysphoria, depression anxiety and the awkwardness of puberty are all real challenges that deserve compassion. But, we should not allow our children to be pushed into experimental surgeries and drugs by radical activist groups and rapacious corporations.
This is not a fringe or controversial position for Missouri legislators or citizens to take. All across the United States, state legislatures and governors are now taking a stand to prevent this horrific abuse of minors. Laws similar to Missouri’s SAFE Act have already passed in Alabama, Arkansas, Mississippi, South Dakota, Tennessee, Texas and Utah, with other states such as Georgia and Indiana sure to follow.
Currently, at least 21 states are considering legislation.
Nationwide, parents are demanding the protection of their children from the predatory behaviors of radical school counselors and agenda-driven medical personnel. Missouri policy leaders must join this fight.
The Senate must allow the “Show Me” state to take the lead, and ensure that S.B. 49 sees whatever floor debate is required and pass it on for consideration by the House. Missouri’s kids deserve nothing less.
And now South Carolina, and a roundup of the issue from the Heritage Foundation.
SC Is Protecting Its Children With “Help Not Harm” Bill. More States Should Follow
Mar 14, 2024 3 min read COMMENTARY BY Sarah Parshall Perry, Senior Legal Fellow, Meese CenterAfter passing a Senate subcommittee just days ago, the bill now heads to the full Senate Medical Affairs Committee for a vote. Lawmakers there must show the courage of their colleagues in the House because the bill is precisely the kind of legislation that America’s children need—and need immediately.
In increasing measure, vulnerable pubescent and pre-pubescent children are being proselytized into a fictional belief that they can be “born in the wrong body.” In fact, so effective have been the influences of social media, peer pressure and pro-trans narratives in this space that UCLA School of Law’s Williams Institute reports that more than 300,000 high school-aged (ages 13-17) children in the United States today identify as “transgender”—making them the largest and fastest-growing share of the overall trans-identified population in the country.
Between 2017 and 2021, the number of children in the United States taking puberty blockers or cross-sex hormones doubled. And double mastectomies performed on adolescent girls increased by nearly 400% during the same period.
These increases aren’t organic. They are a direct result of what appears to be a national social experiment targeting children who are not old enough to vote, get tattoos, buy cigarettes or enter into contracts. The federal government has been working overtime to convince the nation that these experimental procedures are “life-saving care” and that if children don’t have access to these “gender affirming” treatments, they will commit suicide.
But the support for such inflammatory rhetoric simply doesn’t exist. We’re being asked to believe that minor children possess the maturity to make life-altering medical decisions and can fully comprehend the risks of these procedures—those that include everything from incontinence to tissue death to lack of fertility, and worse.
Nothing could be further from the truth.
The increase in a new cohort of the population—de-transitioners—is proof positive of the regretfully life-altering and experimental nature of these kind of “gender affirming” medical interventions. It also demonstrates that children, as easily influenced as they are, must not be used as pawns in a political play that caters to a small but vocal and well-funded minority.
This legislation isn’t hateful or bigoted. It’s a common-sense bill that protects minors when the integrity of their bodies and mental health are on the line. It’s also representative of the widespread and bipartisan support for these kinds of bans, as the majority of Americans oppose “gender affirming care” for minors.
But the tide is turning. Several European countries that once uncritically embraced “gender-affirming care” for minors have already reconsidered or reversed course as the lack of evidence supporting the safety of these procedures and increasing evidence of long-term complications surfaces. The FDA is being sued for allegedly concealing records regarding the off-label use of puberty blockers and cross-sex hormones on minors. Medical malpractice claims against hospital systems that rushed minor children into “gender affirming” surgeries with little to no investigation of the minor’s underlying mental health co-morbidities are on the rise.
Nearly two dozen states have already enacted laws prohibiting “gender-affirming” interventions for minors in most circumstances. Now is the time for South Carolina to join them.
This piece originally appeared in MSN
Yesterday, AAPS (Association of American Physicians and Surgeons) emailed this update:
Building on two recent victories — one in Ohio to protect children from irreversible harm, after we filed a strong amicus brief against transgender procedures on minors, and the second in U.S. Court of Appeals for the 11th Circuit (read our amicus) preventing taxpayer funds from being spent on transgender surgery — AAPS is proud to join a coalition led by the American College of Pediatricians asking the Supreme court of the United States to uphold a Tennessee law blocking transgender operations, and use of related drugs, for children.
Link to Amicus in U.S. vs. Skrmetti: https://aapsonline.org/judicial/amicus-skrmetti-10-18-2024.pdf
Meanwhile, NBC News lays out the legal battleground in Texas.
Texas AG sues doctor accused of providing transgender care to 21 minors
The suit is the first by an attorney general against an individual doctor for allegedly violating a restriction on gender-affirming care for minors. By Matt Lavietes and Jo Yurcaba | Oct. 17, 2024Texas Attorney General Ken Paxton sued a Dallas doctor Thursday accusing her of providing transition-related care to nearly two dozen minors in violation of state law.
Paxton alleged that Dr. May Chi Lau, who specializes in adolescent medicine, provided hormone replacement therapy to 21 minors from October 2023 to August for the purpose of transitioning genders. Texas enacted a law, Senate Bill 14, last year banning hormone replacement therapy and other forms of gender-affirming care for minors.
“Texas passed a law to protect children from these dangerous unscientific medical interventions that have irreversible and damaging effects,” Paxton said in a statement Thursday. “Doctors who continue to provide these harmful ‘gender transition’ drugs and treatments will be prosecuted to the full extent of the law.”
The statement alleged that Lau used "false diagnoses and billing codes" to mask "unlawful prescriptions."
Neither Lau nor her employer, the University of Texas Southwestern Medical Center, immediately replied to requests for comment.
If Lau is found to be in violation of the law, her medical license could be revoked and she could face a financial penalty of hundreds of thousands of dollars.
Paxton’s suit is the first in the country by an attorney general against an individual doctor alleging violation of a restriction on transition-related care for minors.
Texas’ law includes a provision that allows physicians to continue to prescribe puberty blockers and hormone therapy to patients who began treatment before June 1, 2023, in order to wean them off the medications “over a period of time and in a manner that is safe and medically appropriate and that minimizes the risk of complications,” according to Paxton’s suit. Minors are required to have attended at least 12 mental health counseling or psychotherapy sessions for at least six months before they started treatment. It’s unclear whether Lau’s treatment of the minors could fall under that provision.
So far, a few attorneys general, including Paxton, have subpoenaed hospitals and practices that provide such care to minors for those patients’ records. Twenty-six states ban at least some forms of gender-affirming care for minors, according to the Movement Advancement Project, an LGBTQ think tank.
Gov. Greg Abbott signed Texas’ restriction in June 2023, and a court blocked it after families and doctors sued. In September 2023, the Texas Supreme Court allowed the law to take effect pending an appeal from the state, and this June, it vacated and reversed the previous injunction, allowing the law to stand.
The U.S. Supreme Court is expected in its current session to hear oral arguments and rule on whether to strike down a similar law in Tennessee. How the court rules on the Tennessee law is expected to affect similar laws in other states.
The statement from Paxton’s office described gender-affirming care as “experimental, and no scientific evidence supports their supposed benefits.”
Major medical organizations, such as the American Medical Association and the American Academy of Pediatrics, disagree, arguing that transition-related care is an effective and medically necessary way to treat gender dysphoria, which is distress felt by people whose gender identities differ from their genders assigned at birth.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














